Briggs & Stratton’s Vanguard brand expands its EMEA technology network with Mobotic GmbH, combining battery innovation and ...

The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.

Subscribe Login Register Log out My Profile Subscriber Services Search EBLADE ENTER-TO-WIN BLADE REWARDS BLADE VAULT / REPRINTS OBITUARIES JOBS CLASSIFIEDS BLADE HOMES HOMES WEEKLY ADS EVENTS CONTACT ...

The problem of low reaction rate due to poor mass transfer in the two-fluid-phase conventional hydrogenation of unsaturated polymers can be overcome by using dimethyl ether/n-pentane as a light ...